Orphan approvals.
D002210:Caprylates; D002331:Carnitine / Q000172:deficiency / Q000627:therapeutic use; D002769:Cholelithiasis / Q000188:drug therapy; D002951:Citrates / Q000627:therapeutic use; D019343:Citric Acid; D004345:Drug Industry; D005989:Glycerides / Q000627:therapeutic use; D006801:Humans; D009965:Orphan Drug Production; D014481:United States; D014486:United States Food and Drug Administration; D014545:Urinary Calculi / Q000188:drug therapy
D002210:Caprylates; D002951:Citrates; D005989:Glycerides; D019343:Citric Acid; D002331:Carnitine; C025343:monooctanoin